The contributions of Sidney D. Nelson to drug metabolism research

References

• Albano E, Rundgren M, Harvison PJ, et al. (1985). Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol Pharmacol 28:306–311
   PubMed Web of Science ®Google Scholar
• Axworthy DB, Hoffmann KJ, Streeter AJ, et al. (1988). Covalent binding of acetaminophen to mouse hemoglobin. Identification of major and minor adducts formed in vivo and implications for the nature of the arylating metabolites. Chem-Biol Interact 68:99–116
   PubMed Web of Science ®Google Scholar
• Baillie TA. (2012). Sidney D. Nelson (1945–2012). Chem Res Toxicol 25:2–3
   Web of Science ®Google Scholar
• Chen W, Shockcor JP, Tonge R, et al. (1999). Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct. Biochemistry 38:8159–8166
   PubMed Web of Science ®Google Scholar
• Coe KJ, Nelson SD, Ulrich RG, et al. (2006). Profiling the hepatic effects of flutamide in rats: A microarray comparison with classical aryl hydrocarbon receptor ligands and atypical CYP1A inducers. Drug Metab Dispos 34:1266–1275
   PubMed Web of Science ®Google Scholar
• Dahlin DC, Miwa GT, Lu AYH, Nelson SD. (1984). N-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81:1327–1331
   PubMed Web of Science ®Google Scholar
• Dahlin DC, Nelson SD. (1982). Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J Med Chem 25:885–886
   PubMed Web of Science ®Google Scholar
• Dietz EC, Schäfer A, Omichinski JG, Nelson SD. (1997). Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide. Chem Res Toxicol 10:1097–1103
   PubMed Web of Science ®Google Scholar
• Gao Q, Doneanu CE, Shaffer SA, et al. (2006). Identification of the interactions between cytochrome P450 2E1 and cutochrome b5 by mass spectrometry and site-directed mutagenesis. J Biol Chem 281:20404–20417
   PubMed Web of Science ®Google Scholar
• Gordon WP, Forte AJ, McMurty RJ, et al. (1982). Hepatotoxicity and pulmonary toxicity of pennyroyal oil and its constituent terpenes in the mouse. Toxicol Appl Pharmacol 65:413–424
   PubMed Web of Science ®Google Scholar
• Gordon WP, Huitric AC, Seth CL, et al. (1987). The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran. Drug Metab Dispos 15:589–594
   PubMed Web of Science ®Google Scholar
• Harrelson JP, Atkins WM, Nelson SD. (2008). Multiple ligand binding in CYP2A6: Probing mechanisms of cytochrome P450 cooperativity by assessing substrate dynamics. Biochemistry 47:2978–2988
   PubMed Web of Science ®Google Scholar
• Harvison PJ, Nelson SD, Baillie TA. (1988). Unpublished observations
   Google Scholar
• Hinson JA, Nelson SD, Gillette JR. (1979). Metabolism of 18O-phenacetin and 18O-acetaminophen. Mol Pharmacol 15:419–427
   PubMed Web of Science ®Google Scholar
• Hinson JA, Nelson SD, Mitchell JR. (1977). Differences in the microsomal activation of the arylating metabolites formed from p-hydroxyacetanilide and p-ethoxyacetanilide. Mol Pharmacol 13:625–633
   PubMed Web of Science ®Google Scholar
• Hoffmann KJ, Streeter AJ, Axworthy DB, Baillie TA. (1985). Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol Pharmacol 27:566–573
   PubMed Web of Science ®Google Scholar
• Holme JA, Søderlund EJ, Brunborg G, et al. (1989). Different mechanisms are involved in DNA damage, bacterial mutagenicity and cytotoxicity induced by 1,2-bibromo-3-chloropropane in suspensions of rat liver cells. Carcinogenesis 10:49–54
   PubMed Web of Science ®Google Scholar
• Khojasteh-Bakht SC, Koenigs LL, Peter RM, et al. (1998). (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6. Drug Metab Dispos 26:701–704
   PubMed Web of Science ®Google Scholar
• Miller EC, Miller JA. (1947). The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res 7:468–480
   Web of Science ®Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 187:185–194
   PubMed Web of Science ®Google Scholar
• Moore M, Thor H, Nelson S, et al. (1985). The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 260:13035–13040
   PubMed Web of Science ®Google Scholar
• Myers TG, Dietz EC, Anderson NL, et al. (1995). A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3′hydroxyacetanilide. Chem Res Toxicol 8:403–413
   PubMed Web of Science ®Google Scholar
• Nelson SD, Garland WA, Mitchell JR, et al. (1978). Deuterium isotope effects on the metabolism and toxicity of phenacetin in hamsters. Drug Metab Dispos 6:363–367
   PubMed Web of Science ®Google Scholar
• Nelson SD, Mitchell JR, Dybing E, Sasame HA. (1976a). Cytochrome P-450 mediated oxidation of 2-hydroxyestrogens to reactive intermediates. Biochem Biophys Res Commun 70:1157–1165
   PubMed Web of Science ®Google Scholar
• Nelson SD, Mitchell JR, Snodgrass WR, et al. (1976b). Isoniazid and iproniazid: Activation of metabolites to toxic intermediates in man and rat. Science 193:901–903
   PubMed Web of Science ®Google Scholar
• Nelson SD, Omichinski JG, Iyer L, et al. (1984). Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein. Biochem Biophys Res Commun 121:213–219
   PubMed Web of Science ®Google Scholar
• Omichinski JG, Brunborg G, Søderlund EJ, et al. (1987). Renal necrosis and DNA damage caused by selectively deuterated and methylated analogs of 1,2-bibromo-3-chloropropane in the rat. Toxicol Appl Pharmacol 91:358–370
   PubMed Web of Science ®Google Scholar
• Pohl LR, Nelson SD, Garland WA, Trager WF. (1975). The rapid identification of a new metabolite of warfarin via a chemical ionization mass spectrometry ion doublet technique. Biomed Mass Spectrom 2:23–30
   PubMedGoogle Scholar
• Pohl LR, Nelson SD, Krishna G. (1978). Investigation of the mechanism of the metabolic activation of chloramphenicol by rat liver microsomes. Biochem Pharmacol 27:491–496
   PubMed Web of Science ®Google Scholar
• Pohl LR, Nelson SD, Porter WR, et al. (1976). Warfarin – Stereochemical aspects of its metabolism by rat liver microsomes. Biochem Pharmacol 25:2153–2162
   PubMed Web of Science ®Google Scholar
• Proubek DJ, Rundgren M, Harvison PJ, et al. (1987). Investigation of mechanisms of acetaminophen toxicity in isolated rat hepatocytes with the acetaminophen analogues 3,5-dimethylacetaminophen and 2,6-dimethylacetaminophen. Mol Pharmacol 31:647–653
   PubMed Web of Science ®Google Scholar
• Smith CV, Mitchell JR. (1985). Acetaminophen hepatotoxicity in vivo is not accompanied by oxidant stress. Biochem Biophys Res Commun 133:329–336
   PubMed Web of Science ®Google Scholar
• Stepan AF, Walker DP, Bauman J, et al. (2011). Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24:1345–1410
   PubMed Web of Science ®Google Scholar
• Streeter AJ, Baillie TA. (1985). 2-Acetamido-p-benzoquinone: A reactive arylating metabolite of 3′-hydroxyacetanilide. Biochem Pharmacol 34:2871–2876
   PubMed Web of Science ®Google Scholar
• Streeter AJ, Bjorge SM, Axworthy DB, et al. (1984a). The microsomal metabolism and site of covalent binding to protein of 3′-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen. Drug Metab Dispos 12:565–576
   PubMed Web of Science ®Google Scholar
• Streeter AJ, Dahlin DC, Nelson SD, Baillie TA. (1984b). The covalent binding of acetaminophen to protein – Evidence for cysteine residues as major sites of arylation in vitro. Chem-Biol Interact 48:349–366
   PubMed Web of Science ®Google Scholar
• Søderlund EJ, Gordon WP, Nelson SD, et al. (1984). Metabolism in vitro of tris(2,3-dibromopropyl)phosphate: Oxidative bebromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding. Biochem Pharmacol 33:4017–4023
   PubMed Web of Science ®Google Scholar
• Søderlund EJ, Nelson SD, Dybing E. (1981). In vitro and in vivo covalent binding of the kidney carcinogen tris(2,3-dibromopropyl)phosphate. Toxicology 21:291–304
   PubMed Web of Science ®Google Scholar
• Søderlund EJ, Omichinske JG, Dahl JE, et al. (1988). Nephrotoxicity of selectively deuterated and methylated analogues of Tris-BP and Bis-BP in the rat. Pharmacol Toxicol 62:142–149
   PubMedGoogle Scholar
• Takakusa H, Wahlin MD, Zhao C, et al. (2011). Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib. Drug Metab Dispos 39:1022–1030
   PubMed Web of Science ®Google Scholar
• Teng WC, Oh JW, New LS, et al. (2010). Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib. Mol Pharmacol 78:693–703
   PubMed Web of Science ®Google Scholar
• Thomassen D, Knebel N, Slattery JT, et al. (1992). Reactive intermediates in the oxidation of menthofuran by cytochromes P-450. Chem Res Toxicol 5:123–130
   PubMed Web of Science ®Google Scholar
• Tirmenstein MA, Nelson SD. (1989). Homeostasis produced by acetaminophen and a non-hepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver. J Biol Chem 264:9814–9819
   PubMed Web of Science ®Google Scholar
• Wen B, Coe KJ, Rademacher P, et al. (2008). Comparison of in vitro bioactivation of flutamide and its cyano analogue: Evidence for reductive activation by human NADPH: Cytochrome P450 reductase. Chem Res Toxicol 21:2393–2406
   PubMed Web of Science ®Google Scholar
• Wen B, Doneanu CE, Lampe JN, et al. (2005). Probing the CYP3A4 active site by cysteine scanning mutagenesis and photoaffinity labeling. Arch Biochem Biophys 444:100–111
   PubMed Web of Science ®Google Scholar